|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-9-7
|
|
pubmed:abstractText |
Cytomegalovirus (CMV) is one of the serious viral infections after organ transplantation, especially in patients receiving anti-lymphocyte antibodies. Prevention of the infection using antiviral chemotherapy (ganciclovir) has gained interest in the transplant community due to the availability of quantitative methods for viral detection and monitoring.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0041-1345
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1847-9
|
|
pubmed:meshHeading |
pubmed-meshheading:15350495-Adolescent,
pubmed-meshheading:15350495-Adult,
pubmed-meshheading:15350495-Antilymphocyte Serum,
pubmed-meshheading:15350495-Antiviral Agents,
pubmed-meshheading:15350495-Cytomegalovirus Infections,
pubmed-meshheading:15350495-Female,
pubmed-meshheading:15350495-Ganciclovir,
pubmed-meshheading:15350495-Humans,
pubmed-meshheading:15350495-Immunosuppressive Agents,
pubmed-meshheading:15350495-Incidence,
pubmed-meshheading:15350495-Kidney Transplantation,
pubmed-meshheading:15350495-Male,
pubmed-meshheading:15350495-Middle Aged,
pubmed-meshheading:15350495-Postoperative Complications
|
|
pubmed:articleTitle |
Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
|
|
pubmed:affiliation |
Hamed Al-Essa Organ Transplant Center, Ministry of Health, Kuwait. tsaid2000@hotail.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
